Wall Street has maintained its northbound journey in 2026 albeit at a slow pace after an astonishing rally in the last three years. Several stocks have jumped this year. Here, we have five stocks that have surged year-to-date and are currently undervalued.
These stocks currently carry a top Zacks rank, indicating more price upside in the near term. The combination of a top Zacks rank and undervaluation should ensure a continued rally for these stocks in 2026. It is prudent to invest in these stocks now as they are unlikely to stay undervalued for a long time.
These stocks are: Super Micro Computer Inc. SMCI, Archer-Daniels-Midland Co. ADM, The Allstate Corp. ALL, Centene Corp. CNC and Avnet Inc. AVT. Each of our picks currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks year-to-date.
Image Source: Zacks Investment Research
Super Micro Computer Inc.
Super Micro Computer remains positioned to benefit from expanding artificial intelligence (AI) infrastructure demand, supported by rapid adoption of new GPU platforms, its modular Building Block architecture, liquid-cooling expertise and a broader DCBBS offering. SMCI’s strong customer partnership combined with record backlog, rising shipments and expanding product portfolio, positions the company to benefit in the long term.
Solid Estimate Revisions
Super Micro Computer has an expected revenue and earnings growth rate of 71.8% and 22%, respectively, for the current year (ending June 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 30.3% over the last 30 days.
SMCI has an expected revenue and earnings growth rate of 19.6% and 18.7%, respectively, for the next year. The Zacks Consensus Estimate for next year’s earnings has improved 42.2% over the last 30 days.
Attractive Valuation
The stock has a forward price/earnings (P/E) of 8.94X, compared with the industry’s P/E of 10.36X and the S&P 500’s P/E of 18.52X. It has a price/sale (P/S) of 0.67X, compared with the industry’s P/S of 5.32X and the S&P 500’s P/S of 3.09X. SMCI has a price/book (P/B) of 2.32X, significantly lower than the industry’s P/B of 16.38X and the S&P 500’s P/B of 3.71X.
Archer-Daniels-Midland Co.
Archer-Daniels-Midland has been benefiting from its strategic endeavors. ADM continues to advance its Optimize, Drive and Grow pillars, enhancing productivity, accelerating cost savings, expanding BioSolutions and leveraging digital tools to unlock margin opportunities and boost customer reach. ADM’s Human Nutrition unit is gaining from Flavors, Decatur East and emerging demand for natural ingredients.
Solid Estimate Revisions
Archer-Daniels-Midland has an expected revenue and earnings growth rate of 6.6% and 52.2%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 8.5% over the last 60 days.
ADM has an expected revenue and earnings growth rate of 1.4% and 3.5%, respectively, for the next year. The Zacks Consensus Estimate for next year’s earnings has improved 8.4% over the last 60 days.
Attractive Valuation
The stock has a forward P/E of 16.20X, compared with the industry’s P/E of 13.48X and the S&P 500’s P/E of 18.52X. It has a P/S of 0.50X, compared with the industry’s P/S of 0.91X and the S&P 500’s P/S of 3.09X. ADM has a P/B of 1.73X, compared with the industry’s P/B of 0.98X and the S&P 500’s P/B of 3.71X.
The Allstate Corp.
The Allstate has been benefiting from sustained premium growth, expanding market share, and stronger underwriting performance. ALL’s Property-Liability premiums earned rose 4.7% year over year in the first half of 2026, while policies in force increased 2.6%. Protection Services revenues grew 7.5%, driven by Allstate Protection Plans and Roadside. ALL’s Portfolio streamlining, Transformative Growth, and cost discipline are also strengthening profitability.
Solid Estimate Revisions
The Allstate has an expected revenue and earnings growth rate of 5% and 1.9%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 2.1% over the last seven days.
ALL has an expected revenue and earnings growth rate of 4% and -21%, respectively, for the next year. The Zacks Consensus Estimate for next year’s earnings has improved 1% over the last seven days.
Attractive Valuation
The stock has a forward P/E of 7.31X, compared with the industry’s P/E of 11.58X and the S&P 500’s P/E of 18.52X. It has a P/S of 0.94X, compared with the industry’s P/S of 1.35X and the S&P 500’s P/S of 3.09X. ALL has a P/B of 2.07X, compared with the industry’s P/B of 1.68X and the S&P 500’s P/B of 3.71X.
Centene Corp.
Centene has established itself as a national leader in healthcare services. It has a well-diversified healthcare network that primarily provides a set of services to government-sponsored healthcare programs, while serving underinsured and uninsured individuals through member-focused services.
CNC continues to benefit from disciplined pricing, portfolio optimization, favorable Medicaid rate actions, and strong Medicare Prescription Drug Plan momentum. Strategic acquisitions, partnerships, and ongoing enterprise optimization initiatives are strengthening care delivery, improving operational efficiency, and supporting long-term margin restoration.
Solid Estimate Revisions
Centene has an expected revenue and earnings growth rate of 0.8% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.2% over the last 30 days.
CNC has an expected revenue and earnings growth rate of -1.9% and 9.2%, respectively, for the next year. The Zacks Consensus Estimate for next year’s earnings has improved 2.9% over the last 30 days.
Attractive Valuation
The stock has a forward P/E of 13.70X, compared with the industry’s P/E of 23.44X and the S&P 500’s P/E of 18.52X. It has a P/S of 0.16X, compared with the industry’s P/S of 0.30X and the S&P 500’s P/S of 3.09X. CNC has a P/B of 1.46X, compared with the industry’s P/B of 2.50X and the S&P 500’s P/B of 3.71X.
Avnet Inc.
Avnet enters fiscal 2027 with broad-based demand growth, longer lead times and higher backlog supporting further sales and earnings expansion. AVT’s mix of IP&E, embedded solutions, demand creation and supply-chain services should deepen customer ties and support operating leverage as volumes rise. Farnell’s recovery and tighter working-capital execution add to AVT’s upside, while lower leverage should gradually improve financial flexibility.
Solid Estimate Revisions
Avnet has an expected revenue and earnings growth rate of 23.5% and 84.3%, respectively, for the current year (ending June 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 22.9% over the last 30 days.
AVT has an expected revenue and earnings growth rate of 4.4% and 7.4%, respectively, for the next year. The Zacks Consensus Estimate for next year’s earnings has improved 19.9% over the last 30 days.
Attractive Valuation
The stock has a forward P/E of 8.81X, compared with the industry’s P/E of 15.49X and the S&P 500’s P/E of 18.52X. It has a P/S of 0.27X, compared with the industry’s P/S of 0.50X and the S&P 500’s P/S of 3.09X. AVT has a P/B of 1.50X, compared with the industry’s P/B of 1.55X and the S&P 500’s P/B of 3.71X.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Avnet, Inc. (AVT): Free Stock Analysis Report
Archer Daniels Midland Company (ADM): Free Stock Analysis Report
The Allstate Corporation (ALL): Free Stock Analysis Report
Super Micro Computer, Inc. (SMCI): Free Stock Analysis Report
Centene Corporation (CNC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).